CRISPR and Cas Genes Market to Reach US$ 7,234.5 Mn by 2026 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

CRISPR and Cas Genes Market to Reach US$ 7,234.5 Mn by 2026

Description:

Global CRISPR and Cas genes market was valued at US$ 1,451.6 Mn in 2017 and is anticipated to reach US$ 7,234.5 Mn by 2026, expanding at a CAGR of 20.1% from 2018 to 2026. – PowerPoint PPT presentation

Number of Views:0
Date added: 23 January 2020
Slides: 8
Provided by: pharmahealth

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: CRISPR and Cas Genes Market to Reach US$ 7,234.5 Mn by 2026


1
Product - Vector-based Cas, DNA-free Cas
Application - Genome Engineering, Disease Models,
Functional Genomics, Knockdown/Activation End
use - Biotechnology and Pharmaceutical Companies,
Academic and Government Research Institutes,
Contract Research Organizations - Forecast 2018
- 2026
CRISPR and Cas Genes Market
2
Table of Content
Sr. No. Content
Chapter1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary Global CRISPR and Cas Genes Market
Chapter 4 Market Overview
Chapter 5 Global CRISPR and Cas Genes Market Analysis and Forecasts, by Product
Chapter 6 Global CRISPR and Cas Genes Market Analysis and Forecasts, by Application
Chapter 7 Global CRISPR and Cas Genes Market Analysis and Forecasts, by End-user
Chapter 8 Global CRISPR and Cas Genes Market Analysis and Forecasts, by Region
Chapter 9 North America CRISPR and Cas Genes Market Analysis and Forecast
Chapter 10 Europe CRISPR and Cas Genes Market Analysis and Forecast
Chapter 11 Asia Pacific CRISPR and Cas Genes Market Analysis and Forecast
Chapter 12 Latin America CRISPR and Cas Genes Market Analysis and Forecast
Chapter 13  Middle East Africa CRISPR and Cas Genes Market Analysis and Forecast
Chapter 14 Competition Landscape

3
CRISPR and Cas Genes Market Snapshot
  • CRISPR-Cas systems are efficient and easily
    programmable nucleic acid-targeting tools, with
    usage expanding beyond research and therapeutic
    development to precision breeding of plants and
    animals engineering of industrial microbes.
  • CRISPR-Cas systems have potential applications in
    microbial engineering including bacterial strain
    typing, immunization of cultures, autoimmunity or
    self-targeted cell killing, the engineering or
    control of metabolic pathways for improved
    biochemical synthesis.
  • Rise in government spending on research and
    development of genome editing, increase in
    incidence of genetic disorders, and usage of
    CRISPR/Cas9 technology to improve crop production
    drive the global CRISPR and Cas genes market.
  • Major players operating in the global CRISPR and
    Cas genes market include Synthego, Thermo Fisher
    Scientific, Inc., GenScript, Addgene, Merck KGaA
    (Sigma-Aldrich), Integrated DNA Technologies,
    Inc., Transposagen Biopharmaceuticals, Inc.,
    OriGene Technologies

4
(No Transcript)
5
Reports Highlights
  • Global CRISPR and Cas genes market was valued at
    US 7,234.5 Mn by 2026, expanding at a CAGR of
    around 20.1 from 2018 to 2026.
  • Increase in applications of CRISPR and Cas gene
    editing technology in bacteria and usage of gene
    editing technology for prevention of various
    diseases are the major factors anticipated to
    drive the market from 2018 to 2026.
  • Genome editing technologies such as CRISPR/Cas9
    is a revolutionary step in the field of
    biomedical research.
  • The global CRISPR and Cas genes market has been
    segmented based on product type, application,
    end-user, and region.
  • Applications of CRISPR and Cas Genes Market
    Genome Engineering, Disease Models, Functional
    Genomics, Knockdown/activation, Others

Request Sample
6
Continue..
  • In September, 2017, Amgen Inc. And ALLERGAN
    Collectively Obtained FDA Approval For The Use Of
    MVASI To Treat Five Types Of Cancer.
  • Continuous Launch Of New Products And Increase In
    The Number Of Patients In Developed And
    Developing Countries.
  • Expansion Of Drugs Delivery System Portfolio By
    Improving Existing Drug Delivery Devices And
    Developing And Launching Of New Drug Delivery
    System Through Collaboration.

Request Brochure
7
(No Transcript)
About PowerShow.com